Data management

63 Results

Virtual Trials: Trust in Experience, Trust in Lunexis™

Clinical Ink | 24-Mar-2021 | Data Sheet

From Infectious Disease to BYOD, We Set the Bar for Virtual Trials

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Introduction to eLAS®

Clinical Ink | 08-Mar-2021 | Product Brochure

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®) to address fundamental challenges impacting systemic lupus...

Flexible eConsent options to support remote consent for standard, virtual, or hybrid clinical studies

Signant Health | 05-Mar-2021 | Product Brochure

Signant Health understands that obtaining informed consent goes beyond a signature. In addition to increasing study participant comprehension, utilizing...

Deploy Configurable, Mixed-Modality ePRO Solutions, Fast

Clinical Ink | 01-Mar-2021 | Data Sheet

Real-Time, Integrated Data Capture With Unprecedented Freedom of Choice

A Winning End-to-End Solution for Oncology Studies

Clinical Ink | 22-Feb-2021 | Technical / White Paper

Oncology clinical trials present a unique set of challenges for patients, study sites, and study sponsors. Using electronic patient reported outcomes (ePRO)...

Why automating clinical trials is essential

Formedix | 18-Jan-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Outsourcing Analytical Testing for Biologics - A CRO's Perspective

Frontage Laboratories | 01-Dec-2019 | Technical / White Paper

Biologics are complex large molecules derived from living organisms or manufactured from cells, and they have inherent structural heterogeneity. Indeed,...

How to Avoid Surprises in Small-Molecule Drug Development Programs

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Over the years, the pharmaceutical industry has made steady progress in improving the safety of drugs in development. Consequently, in 2015, only 14 percent...